Genetic News and Research

RSS

New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

The first generation of COVID-19 vaccines have been highly effective, but also have limitations: their efficacy can wane without a booster shot, and they may be less effective against some variants.

2 Feb 2022

Study finds minimal genetic difference between healthy sea stars and those with wasting syndrome

Healthy-looking ochre sea stars have minimal genetic difference from those displaying symptoms of sea star wasting syndrome, say Oregon State University researchers who examined whether genetic variation was the reason some animals went unaffected during an epidemic of the deadly disease.

2 Feb 2022

Liver hormone suppresses alcohol consumption in primates, study shows

A hormone produced by the liver called fibroblast growth factor 21 (FGF21) suppresses alcohol consumption in primates, finds a study published February 1 in the journal Cell Metabolism.

1 Feb 2022

Nanomedicine can be improved with proper and more predictive in vitro assays

Messenger RNA (mRNA) vaccines are a prime example of the promising field of nanomedicine. But progress in the design and application of nanoparticles as efficient delivery vehicles for biopharmaceutics containing nucleic acid or protein drug substances is, unfortunately, remarkably slow.

1 Feb 2022

Developing post-vaccination SARS-CoV-2 standard reference sera

A new study reports the generation of reference sera reagents that were obtained from subjects vaccinated with one of four COVID-19 vaccines.

1 Feb 2022

Study suggests an etiological link between obesity and female reproductive disorders

Obesity is associated with an increased risk of developing female reproductive disorders, however, the roles and mechanisms of obesity in the cause(s) of reproductive conditions are unclear.

1 Feb 2022

Study finds disparities in COVID-19 vaccine hesitancy and uptake among racial, ethnic minorities

People from racial and ethnic minorities in the United States and the United Kingdom were up to three times as likely to report being unsure or unwilling to get a COVID-19 vaccine during the initial vaccine rollout compared to white participants, found a study published in Nature Communications.

1 Feb 2022

Researchers discover why patients suffering with hypertension also have diabetes

The long-standing enigma of why so many patients suffering with high blood pressure (known as hypertension) also have diabetes (high blood sugar) has finally been cracked by an international team led by the universities of Bristol, UK, and Auckland, New Zealand.

1 Feb 2022

New RNA therapies for the treatment of heart failure and organ fibrosis

RNA has already been making an impact in the context of the vaccine program, but the potential of RNA-based compounds is far from being fully tapped, as RNA allows for entirely new therapeutic approaches.

1 Feb 2022

Stigma around birth defects still plagues people in Africa

Cynthia Solomon, a 45-year-old businesswoman in Nigeria, started having issues in her matrimonial home when she gave birth to two children with Down syndrome.

1 Feb 2022

Families of Black patients found to have greater risk for dilated cardiomyopathy

Black patients diagnosed with dilated cardiomyopathy (DCM) of unknown cause are more likely to have family members at risk of developing the heart muscle disease than families of white patients, according to results of a multi-site study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine.

1 Feb 2022

SARS-CoV-2 protein NSP2 found to impair microRNA-induced gene silencing in human cells

In a new study, a team of researchers used co-immunoprecipitation and in vitro interaction assays to identify the molecular basis of interaction of SARS-CoV-2 non-structural protein 2 with eIF4E-homologous protein (4EHP)-GRB10-interacting glycine-tyrosine-phenylalanine domain protein 2 complex, involved in microRNA-mediated gene silencing in human cells.

1 Feb 2022

Ingenza collaborates with Johnson Matthey for efficient industrial enzyme synthesis

Biotechnology company Ingenza is excited to report the successful conclusion to its recent six-month project with Johnson Matthey.

1 Feb 2022

Study highlights importance of immunizing and boosting PAD syndromes patients with SARS-CoV-2 mRNA vaccines

A new study posted to the medRxiv* preprint server has evaluated the effect of mRNA-based COVID-19 vaccination and boosting strategy on serum antibody responses in PAD patients against the original SARS-CoV-2 strain and circulating variants.

31 Jan 2022

New study on mutation origination fundamentally challenges neo-Darwinism

A new study by a team of researchers from Israel and Ghana has brought the first evidence of nonrandom mutation in human genes, challenging a core assumption at the heart of evolutionary theory by showing a long-term directional mutational response to environmental pressure.

31 Jan 2022

Genetic News and Research

New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

Study finds minimal genetic difference between healthy sea stars and those with wasting syndrome

Liver hormone suppresses alcohol consumption in primates, study shows

Nanomedicine can be improved with proper and more predictive in vitro assays

Developing post-vaccination SARS-CoV-2 standard reference sera

Study suggests an etiological link between obesity and female reproductive disorders

Study finds disparities in COVID-19 vaccine hesitancy and uptake among racial, ethnic minorities

Researchers discover why patients suffering with hypertension also have diabetes

New RNA therapies for the treatment of heart failure and organ fibrosis

Stigma around birth defects still plagues people in Africa

Families of Black patients found to have greater risk for dilated cardiomyopathy

SARS-CoV-2 protein NSP2 found to impair microRNA-induced gene silencing in human cells

Ingenza collaborates with Johnson Matthey for efficient industrial enzyme synthesis

Study highlights importance of immunizing and boosting PAD syndromes patients with SARS-CoV-2 mRNA vaccines

New study on mutation origination fundamentally challenges neo-Darwinism

Placental ACE2 shedding may block SARS-CoV-2 transmission to babies during pregnancy

Researchers identify genetic cause of rare interstitial lung disease in a young child

It’s Day 6 of covid, and a rapid antigen test comes back positive. stay home, say virologists.

Study finds how a change in cell environment triggers autism with genetic vulnerability

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

eBook: Using iPSCs models for human disease research and drug discovery eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News